type

Antineoplastic drugs

name

Doxorubicin Hydrochloride Liposome Injection

specs

10ml:10ml:20mg/80box

Drug approval number

国药准字H20233173

Indications

This product can be used for patients with low CD4 (<200CD4 lymphocytes/mm³) and AIDS-related Kapos's sarcoma (AIDS-KS) with extensive skin and mucosal visceral diseases.This product can be used as a first-line systemic chemotherapy drug, or as a second-line chemotherapy drug for the treatment of AIDS-KS patients with progression, and can also be used for patients who cannot tolerate the combination of two or more of the following drugs:vincristine, bleomycin and doxorubicin (or other anthracycline antibiotics).

type

Antineoplastic drugs

name

Irinotecan hydrochloride liposomal injection

Product progress

Marketing Approval Application

Indications

In combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic pancreatic cancer who have progressed after treatment with gemcitabine.